# Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine

> **NCT00626743** · PHASE1 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 13 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** SK3530 100mg, Placebo, Amlodipine

## Key facts

- **NCT ID:** NCT00626743
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-05
- **Final completion:** 2011-07
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00626743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00626743, "Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00626743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*